Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Arcutis Biotherapeutics, Inc. (ARQT) had Return on Assets of -3.73% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$376.07M |
|
$-16.14M |
|
$36.70M |
|
$339.38M |
|
$388.30M |
|
$-12.23M |
|
$-2.74M |
|
$-14.97M |
|
$-14.97M |
|
$-16.14M |
|
$-16.14M |
|
$-16.14M |
|
$-16.14M |
|
$-12.23M |
|
$-9.65M |
|
127.23M |
|
127.23M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$411.23M |
|
$1.04M |
|
$21.74M |
|
$432.97M |
|
$129.84M |
|
$107.96M |
|
$113.66M |
|
$243.49M |
|
$189.48M |
|
$174.67M |
|
$189.48M |
|
123.33M |
|
| Cash Flow Statement Financials | |
$-5.62M |
|
$-30.25M |
|
$6.97M |
|
$71.95M |
|
$43.22M |
|
$-28.74M |
|
$40.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.17 |
|
-- |
|
-- |
|
0.36 |
|
0.57 |
|
90.24% |
|
-3.25% |
|
-3.25% |
|
-2.57% |
|
-3.98% |
|
-4.29% |
|
$-6.31M |
|
-- |
|
-- |
|
-- |
|
0.87 |
|
1.62 |
|
2.57 |
|
141.92 |
|
-8.52% |
|
-9.24% |
|
|
Return on Assets |
-3.73% |
-5.43% |
|
$1.54 |
|
$-0.05 |
|
$-0.04 |
|